• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Physicians to pharmas: provide patient services or face irrelevance

Physicians to pharmas: provide patient services or face irrelevance

October 17, 2014
CenterWatch Staff

Physicians are looking to pharmaceutical companies to help them keep patients engaged in their healthcare by providing patient services, according to the ePharma Physician 2014 study from Manhattan Research, part of Burlington, Mass.-based Decision Resources Group.

The study showed strong physician interest in patient support and resources from pharma, along with an expectation that the industry will take a leadership role in developing tools to help keep patients on track and improve patient outcomes. These findings come as accountable care organizations and meaningful use stage 2 incentives are pushing patient engagement to the forefront for healthcare providers and systems.

Key findings from the study include:

  • Seven out of 10 ePharma physicians somewhat or strongly agreed that pharmas must provide more resources and services alongside drugs and treatments to stay relevant in the emerging healthcare system
  • 35% of ePharma physicians said pharmas have a key role to play in driving progress in defining and meeting patient outcomes
  • One in five ePharma physicians strongly agreed that they were interested in using patient resources from pharma that would help them meet patient outcomes goals
  • Sales reps are the top source from which ePharma physicians want to learn about patient support and resources from pharma, followed by professional journals or web sites intended for a healthcare professional audience, and by email newsletters from pharma.

Monique Levy, vice president of research, said, “Physicians are connecting the dots. They understand that to succeed in an outcomes-based reimbursement model, they need to engage patients more. Pharma can provide them tools to help with this."

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing